REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Farmasi R.S. Sdn. Bhd. (Malaysia)

Main Activities: Pharmaceutical and Medicine Manufacturing | Pharmacies and Drug Stores
Full name: Farmasi R.S. Sdn. Bhd. Profile Updated: January 24, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Farmasi R.S. Sdn. Bhd. is an enterprise located in Malaysia, with the main office in Ipoh. The company operates in the Pharmaceutical and Medicine Manufacturing sector. It was first established on July 27, 1990. In 2024, the company reported a net sales revenue increase of 1.69%. Over the same period, its total assets grew by 17.93%. The net profit margin of Farmasi R.S. Sdn. Bhd. increased by 8.8% in 2024.

Headquarters
361 & 363, Jalan Silibin, Taman Saz
Ipoh; Perak; Postal Code: 30100

Contact Details: Purchase the Farmasi R.S. Sdn. Bhd. report to view the information.

Basic Information
Registered Capital:
Purchase the Farmasi R.S. Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Farmasi R.S. Sdn. Bhd. report to view the information.
Incorporation Date:
July 27, 1990
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Subsidiaries
Biomiicron (M) Sdn. Bhd.
75%
Nattura Holdings Sdn. Bhd.
25%
Company Performance
Financial values in the chart are available after Farmasi R.S. Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
1.69%▲
Total operating revenue
1.69%▲
Operating profit (EBIT)
72.98%▲
EBITDA
70.01%▲
Net Profit (Loss) for the Period
71.33%▲
Total assets
17.93%▲
Total equity
-8.57%▼
Operating Profit Margin (ROS)
9.56%▲
Net Profit Margin
8.8%▲
Return on Equity (ROE)
20.52%▲
Quick Ratio
-0.24%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo